BOLD
Boundless Bio, Inc. Common Stock
NASDAQ: BOLD · HEALTHCARE · BIOTECHNOLOGY
$1.46
+0.69% today
Updated 2026-04-30
Market cap
$33.61M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.60
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
Boundless Bio, Inc. Common Stock (BOLD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-49.02M | $-84.51M | $-107.98M | $-23.25M | $-39.60M | $-46.85M | $-60.84M | $-46.66M |
| Capital expenditures | $16.65M | $7.55M | $11.61M | $2.03M | $1.07M | $633000.00 | $2.54M | $546000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.00M | $6.88M | $16.50M | $1.16M | $2.29M | $3.34M | $7.52M | $6.13M |
| Free cash flow | $-65.67M | $-92.06M | $-119.59M | $-25.28M | $-40.66M | $-47.49M | $-63.38M | $-47.21M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |